Trilegal’s Mumbai office is advising Glenmark Generics (GG) to raise Rs. 570 Crore ($118 Million) through an IPO, valuing GG at about Rs. 4,800 Crores ($ 1 Billion). Glenmark Generics’ parent company, Glenmark Pharma (GP), and its affiliates own about 97 percent in GG.
